Immunocytochemistry further validated robust expression of diverse pluripotency markers, including SSEA-4, TRA-1-60, TRA-1-81, OCT4, SOX2, KLF4 and NANOG in HK-derived iPS clones regardless of patient age and status of diabetes (Figure 1C). The gene discussed is SOX2; the disease is diabetes mellitus.